Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bio Key International (BKYI) Revenue (2016 - 2025)

Bio Key International (BKYI) has disclosed Revenue for 16 consecutive years, with $1.5 million as the latest value for Q3 2025.

  • Quarterly Revenue fell 27.75% to $1.5 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $6.3 million through Sep 2025, down 13.39% year-over-year, with the annual reading at $6.9 million for FY2024, 10.64% down from the prior year.
  • Revenue hit $1.5 million in Q3 2025 for Bio Key International, down from $1.7 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $2.2 million in Q1 2023 to a low of $934932.0 in Q4 2021.
  • Historically, Revenue has averaged $1.7 million across 5 years, with a median of $1.8 million in 2022.
  • Biggest five-year swings in Revenue: skyrocketed 261.47% in 2021 and later crashed 40.83% in 2024.
  • Year by year, Revenue stood at $934932.0 in 2021, then soared by 88.08% to $1.8 million in 2022, then rose by 3.79% to $1.8 million in 2023, then dropped by 19.88% to $1.5 million in 2024, then increased by 5.98% to $1.5 million in 2025.
  • Business Quant data shows Revenue for BKYI at $1.5 million in Q3 2025, $1.7 million in Q2 2025, and $1.6 million in Q1 2025.